World Health Assembly Adopts Landmark Resolution on Steatotic Liver Disease, Marking a Historic First for Global NCD Policy
PRESS RELEASE Geneva, 22 May 2026 For the first time, liver disease receives formal recognition within the global noncommunicable disease agenda — EASL hails the adoption of WHO resolution EB158/CONF./7 as a…
A tribute to Dr Hannes Hagström
EASL is deeply saddened by the passing of Dr Hannes Hagström, Consultant Hepatologist at Karolinska University Hospital and Professor at Karolinska Institutet. Hannes was not only an exceptional clinician scientist, but also…
A-TANGO related activities at EASL Congress 2026
Friday, 29 May 2026 A-TANGO Consensus Conference The A-TANGO Score: A Novel Tool for Risk Stratification and Clinical Endpoints in ACLF Rajiv Jalan (UCL) and Cornelius Engelmann (Charité) Track Hub 6 -…
MICROB-PREDICT related activities at EASL Congress 2026
Wednesday, 27 May 2026 MICROB-PREDICT Consensus Conference Microbiome-based mechanisms and biomarkers for improved patient stratification & therapeutic response prediction in decompensated cirrhosis and ACLF Jansen Room 15:30 – 18:30 h View agenda…
DECISION related activities at EASL Congress 2026
DECISION members at EASL Congress: Talks Wednesday, 27 May
New Lancet Commission calls for urgent action to tackle Europe’s rising liver disease burden
New Lancet Commission calls for urgent action to tackle Europe's rising liver disease burden Every day in Europe, nearly 780 people die from cirrhosis or liver cancer — conditions that are largely…
EASL General Assembly 2026
The EASL General Assembly will take place on Friday, 29 May 2026, from 18:45 to 20:00 during EASL Congress 2026 in Barcelona. The meeting will be held in person in the Mondelli…